DNMT3B Gene Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome Type 1 Genetic Test sale cost 4400 AED
IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant Genetic Test sale cost 4400 AED IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
POMP Gene Keratosis Linearis with Ichthyosis Congenita and Sclerosing Keratoderma Genetic Test sale cost 4400 AED POMP Gene Keratosis Linearis with Ichthyosis Congenita and Sclerosing Keratoderma Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

DNMT3B Gene Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DNMT3B Gene Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome Type 1 (ICF1) Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the DNMT3B gene. These mutations are responsible for ICF syndrome type 1, a rare autosomal recessive disorder characterized by immunodeficiency, centromeric region instability, and distinctive facial anomalies. The condition leads to a compromised immune system, making individuals susceptible to infections, and can present various developmental and physical challenges.

The test, priced at 4400 AED, involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory to detect abnormalities in the DNMT3B gene. The goal is to provide a definitive diagnosis, enabling tailored medical care and management plans for affected individuals. DNA Labs UAE utilizes advanced genetic testing technologies to ensure accurate and reliable results, supporting families and healthcare providers in understanding and addressing the complexities of ICF syndrome type 1.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DNMT3B Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 Genetic Test

Test Name: DNMT3B Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for DNMT3B Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DNMT3B Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 NGS Genetic DNA Test gene DNMT3B

Test Details: DNMT3B gene immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) is a rare genetic disorder characterized by immunodeficiency, centromeric instability, and facial anomalies. It is caused by mutations in the DNMT3B gene, which plays a role in DNA methylation and gene regulation. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of ICF1, NGS genetic testing can be used to identify mutations or variants in the DNMT3B gene that are associated with the syndrome. NGS genetic testing for ICF1 involves obtaining a DNA sample, typically through a blood sample, and analyzing the DNA for mutations or variants in the DNMT3B gene. The DNA sample is sequenced using NGS technologies, which can identify specific changes in the DNA sequence. The results of the test can then be used to confirm a diagnosis of ICF1 and provide information about the specific genetic mutation or variant present. NGS genetic testing for ICF1 can be useful for individuals who have symptoms or a family history suggestive of the syndrome. It can help confirm a diagnosis, provide information about the genetic cause of the syndrome, and guide treatment and management options. Genetic counseling is often recommended before and after NGS genetic testing to discuss the implications of the test results and provide support to individuals and families affected by ICF1.

Test Name DNMT3B Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DNMT3B Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DNMT3B Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 NGS Genetic DNA Test gene DNMT3B
Test Details

DNMT3B gene immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) is a rare genetic disorder characterized by immunodeficiency, centromeric instability, and facial anomalies. It is caused by mutations in the DNMT3B gene, which plays a role in DNA methylation and gene regulation.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of ICF1, NGS genetic testing can be used to identify mutations or variants in the DNMT3B gene that are associated with the syndrome.

NGS genetic testing for ICF1 involves obtaining a DNA sample, typically through a blood sample, and analyzing the DNA for mutations or variants in the DNMT3B gene. The DNA sample is sequenced using NGS technologies, which can identify specific changes in the DNA sequence. The results of the test can then be used to confirm a diagnosis of ICF1 and provide information about the specific genetic mutation or variant present.

NGS genetic testing for ICF1 can be useful for individuals who have symptoms or a family history suggestive of the syndrome. It can help confirm a diagnosis, provide information about the genetic cause of the syndrome, and guide treatment and management options. Genetic counseling is often recommended before and after NGS genetic testing to discuss the implications of the test results and provide support to individuals and families affected by ICF1.

SKU: TEST-3097 Category:

Related products